Dr. Hakan Ismail Sari
Consultor Sênior em Hematologia
Hospital Memorial AtasehirIstambul, Turquia
25 + anos De experiência
Sobre o médico
Qualificações:
- MD em Medicina Interna
- Specialist in Hematology
Visão geral:
Prof Dr. Hakan Ismail Sari is a distinguished hematologist with a profound impact on the field of blood diseases. Currently serving at Memorial Atasehir Hospital in Istanbul, he brings over 25 years of experience in diagnosing and treating complex hematological conditions.
His medical journey commenced with a specialization in internal medicine, followed by a focus on hematology. He has held significant positions, including:
- Hematology Specialist and Deputy Chief Physician at Golcuk Military Hospital (2006–2015)
- Hematology and Internal Medicine Specialist at Erciyes University (1998–2006)
Beyond his clinical roles, Prof. Dr. Sari contributes to the academic community as an Editorial Board Member of the journal "Transfusion and Apheresis Science" and serves as an educator, shaping future medical professionals
His commitment to patient care, combined with his academic contributions, underscores his reputation as a leading figure in hematology.
Condições tratadas
- Leucemia
- linfoma
- Mieloma múltiplo
- Anemia
- Trombocitopenia
- Hemofilia
- Síndromes Mielodisplásicas
- Anemia aplástica
- Policitemia Vera
- Talassemia
Procedimentos Executados
- Biópsia da Medula Óssea
- Quimioterapia para neoplasias hematológicas
- Transplante de Células-Tronco
- Aférese
- imunoterapia
- Terapia direcionada
- Gestão de distúrbios hemorrágicos
- Terapia de Transfusão de Sangue
Envie sua solicitação de tratamento
Perguntas
He is proficient in English and Turkish, facilitating communication with international patients.
Appointments can be arranged directly through Memorial Atasehir Hospital. Alternatively, HOSPIDIO offers assistance in booking consultations. Contact us at [email protected] or via Call/WhatsApp at +91-9870538337 for support.
Yes, online consultations are available. Please reach out to HOSPIDIO to coordinate virtual appointments.
He employs a patient-centric approach, integrating the latest advancements in hematology to devise personalized treatment plans.
Yes, he actively contributes to medical research and serves on the editorial board of "Transfusion and Apheresis Science," reflecting his commitment to advancing the field